[go: up one dir, main page]

AR028706A1 - Tiazina oxazolidinona - Google Patents

Tiazina oxazolidinona

Info

Publication number
AR028706A1
AR028706A1 ARP010102780A ARP010102780A AR028706A1 AR 028706 A1 AR028706 A1 AR 028706A1 AR P010102780 A ARP010102780 A AR P010102780A AR P010102780 A ARP010102780 A AR P010102780A AR 028706 A1 AR028706 A1 AR 028706A1
Authority
AR
Argentina
Prior art keywords
tiazina
oxazolidinona
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
ARP010102780A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AR028706A1 publication Critical patent/AR028706A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Tiazina oxazolidinona util como agente antimicrobiano de formula (1) o una sal de éste farmacéuticamente aceptable.
ARP010102780A 2000-06-16 2001-06-12 Tiazina oxazolidinona AR028706A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21247400P 2000-06-16 2000-06-16
US23659500P 2000-09-29 2000-09-29
US28558701P 2001-04-20 2001-04-20

Publications (1)

Publication Number Publication Date
AR028706A1 true AR028706A1 (es) 2003-05-21

Family

ID=27395744

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102780A AR028706A1 (es) 2000-06-16 2001-06-12 Tiazina oxazolidinona

Country Status (16)

Country Link
US (1) US6605609B2 (es)
EP (1) EP1294717B1 (es)
JP (1) JP2004501150A (es)
KR (1) KR20030010721A (es)
CN (1) CN1430618A (es)
AR (1) AR028706A1 (es)
AT (1) ATE312098T1 (es)
AU (1) AU2001266567A1 (es)
BR (1) BR0111520A (es)
CA (1) CA2410358A1 (es)
DE (1) DE60115644T2 (es)
ES (1) ES2253392T3 (es)
MX (1) MXPA02012494A (es)
PE (1) PE20020044A1 (es)
TW (1) TW583184B (es)
WO (1) WO2001098297A2 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6774231B2 (en) 2001-04-20 2004-08-10 Pharmacia & Upjohn Company Method for the preparation of oxazolidinones
AU2002255803B2 (en) 2001-04-20 2008-07-03 Pharmacia And Upjohn Company Process to prepare oxazolidinones
CA2453182A1 (en) * 2001-07-10 2003-01-23 Meredith L. Greene Crystalline thiazine oxazolidinones
AU2003224345A1 (en) * 2002-04-30 2003-11-17 Orchid Chemicals & Pharmaceuticals Antibacterial agents
WO2004071368A2 (en) * 2002-05-07 2004-08-26 The State University Of New York At Stony Brook Methods, devices and formulations for targeted endobronchial therapy
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
TWI357901B (en) 2004-03-12 2012-02-11 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivati
WO2005113520A1 (en) * 2004-05-20 2005-12-01 Pharmacia & Upjohn Company Llc Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
BRPI0614758A2 (pt) * 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
CN102202649A (zh) 2008-10-07 2011-09-28 Mpex医药有限公司 用于改进的药物动力学的氟喹诺酮气雾剂制剂
KR20120100904A (ko) 2009-09-04 2012-09-12 엠펙스 파마슈티컬즈, 인코포레이티드 낭포성 섬유증을 치료하기 위한 에어로졸화된 레보플록사신의 용도
US10010758B2 (en) * 2015-07-20 2018-07-03 Kinetic Furniture Of Vermont, Llc Exercise chair
CN106770222A (zh) * 2016-11-23 2017-05-31 百奥森（江苏）食品安全科技有限公司 一种食品中甲硝唑的检测试剂盒
CN108239098B (zh) * 2016-12-26 2021-01-12 中国医学科学院药物研究所 含四氢吡啶的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
AU2018250596A1 (en) * 2017-04-14 2019-10-31 Y. Joseph Mo Pre-filled syringe containing moxifloxacin
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
CN111870594B (zh) * 2020-08-27 2022-03-22 首都医科大学附属北京胸科医院 苯乙肼在制备抗偶发分枝杆菌感染的药物中的应用
EP4568961A1 (en) * 2022-08-10 2025-06-18 Merck Sharp & Dohme LLC Processes for preparing oxazolidinone compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
AU716493B2 (en) 1995-09-01 2000-02-24 Pharmacia & Upjohn Company Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
JP2001524074A (ja) * 1997-03-13 2001-11-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 金属−β−ラクタマーゼ阻害特性を有するピロリジンおよびチアゾール誘導体
AU1572101A (en) 1999-11-08 2001-06-06 Pharmacia & Upjohn Company Admixture of linezolid and other antibacterial agents

Also Published As

Publication number Publication date
WO2001098297A2 (en) 2001-12-27
TW583184B (en) 2004-04-11
US20020156072A1 (en) 2002-10-24
WO2001098297A3 (en) 2002-06-13
PE20020044A1 (es) 2002-01-30
DE60115644T2 (de) 2006-07-06
DE60115644D1 (en) 2006-01-12
ES2253392T3 (es) 2006-06-01
US6605609B2 (en) 2003-08-12
CN1430618A (zh) 2003-07-16
EP1294717B1 (en) 2005-12-07
KR20030010721A (ko) 2003-02-05
BR0111520A (pt) 2003-03-18
ATE312098T1 (de) 2005-12-15
JP2004501150A (ja) 2004-01-15
CA2410358A1 (en) 2001-12-27
MXPA02012494A (es) 2003-04-25
EP1294717A2 (en) 2003-03-26
AU2001266567A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AR028706A1 (es) Tiazina oxazolidinona
ATE376996T1 (de) Antibakterielle mittel
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
MA27643A1 (fr) Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens
PT1193270E (pt) Pirrolobenzodiazepinas
NO995846L (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AR024077A1 (es) Compuestos antibacterianos
EP1334720A4 (en) Nateglinide-containing preparations
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
ES2159591T3 (es) Composicion de liberacion controlada.
DE60009905D1 (de) Peroxycarbonsäure und ihre wässrigen zusammensetzungen
AU2001266575A1 (en) Chemical compounds
EP1037650A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS
DE60131960D1 (de) Fungizide zusammensetzungen, die n-(alpha-cyano-2-thenyl)-4-ethyl-2-ethylamino-5-thiazolcarboxamide enthalten
BR0010982A (pt) Novas oxazolidinonas bicìclicas como agentes antibacterianos
SE0003476D0 (sv) Compounds
DE60112960D1 (de) Kondensierte pyridoindolderivate
DK1305037T3 (da) Smertestillende medikament
UA83266C2 (en) Oxazole derivatives of tetracyclines
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE250610T1 (de) Kaliumkanal-blockierende mittel
DK1073447T3 (da) N1-modificerede glycopeptider

Legal Events

Date Code Title Description
FB Suspension of granting procedure